Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-26-000008

Chief Executive Officer sold 18,703 shares at $27.09 ($506,664)

  • Chief Executive Officer acquired 38,278 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goff Brian · Chief Executive Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-30 Exercise or conversion : show line 1 in the form 10b5-1 +25,528 149,056 D
2025-12-30 Sale : show line 2 in the form 10b5-1 −12,473 $27.09 $337,894 136,583 D
2025-12-30 Exercise or conversion : show line 3 in the form 10b5-1 +12,750 149,333 D
2025-12-30 Sale : show line 4 in the form 10b5-1 −6,230 $27.09 $168,771 143,103 D
Open-market sales · 18,703 sh · avg $27.09 · $506,664

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-12-30 Exercise or conversion : show line 5 in the form 10b5-1 Performance share units −25,528 25,528 D
2025-12-30 Exercise or conversion : show line 6 in the form 10b5-1 Performance share units −12,750 0 D
Loading xslF345X05/wk-form4_1767402967.xml…